Aligos Therapeutics, Inc. (ALGS) Capital expenditures 2019–2024
Aligos Therapeutics, Inc. (ALGS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$130,000FY2024 · since FY2019: $2.8M → $130,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $130,000 | +584.2% |
| FY2023 | $19,000 | -98.0% |
| FY2022 | $943,000 | +5.7% |
| FY2021 | $892,000 | -56.8% |
| FY2020 | $2.1M | -25.9% |
| FY2019 | $2.8M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice